The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EMN 2018 | Combatting oral mucositis with cryotherapy after high dose melphalan
Monika Engelhardt
• 19 Apr 2018
Monika Engelhardt, MD, of the University Medical Center Freiburg, Freiburg, Germany, discusses a promising study conducted at her center using oral cryotherapy to prevent mucositis in patients treated with high dose melphalan chemotherapy. This video was recorded at the 1st European Myeloma Network (EMN) Meeting 2018, held in Turin, Italy.
